Vaginal Cancer Incidence Increasing Globally
By Lori Solomon HealthDay Reporter
WEDNESDAY, July 3, 2024 -- The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics and Gynaecology.
Junjie Huang, from the Chinese University of Hong Kong, and colleagues investigated the incidence, risk factors, and trends for vaginal cancer using data from the Global Cancer Observatory, Cancer Incidence in Five Continents Plus, Global Burden of Disease, World Bank, and the United Nations.
The researchers found that in 2020, there were 17,908 newly reported cases of vaginal cancer (age-standardized rate [ASR], 0.36), with the highest ASRs reported in South-Central Asia and Southern Africa. A higher incidence of vaginal cancer was associated with a higher prevalence of unsafe sex and HIV infection. Over time, there was rising incidence globally, with Iceland (average annual percentage change [AAPC], 29.56), Chile (AAPC, 22.83), Bahrain (AAPC, 22.05), and the United Kingdom (AAPC, 1.40) showing the most significant rising trends.
"The increasing incidence trend emphasizes the need for enhanced human papillomavirus vaccination rates to prevent the development of vaginal cancer," the authors write. "Education should be provided to individuals in high-risk regions about the dangers of unsafe sex and the importance of human papillomavirus vaccination."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted July 2024
Read this next
Nudging Both Clinicians, Patients May Increase Serious Illness Conversations
TUESDAY, July 2, 2024 -- Combining clinician- and patient-directed nudges may help to promote serious illness conversations (SICs) in cancer care, according to a study published...
Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer
TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...
Racial Differences Seen in Financial Hardship Among Older Cancer Survivors
MONDAY, July 1, 2024 -- Income and area-level disadvantage are the largest contributors to racial differences in financial hardship among older U.S. adults with cancer, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.